Literature DB >> 22699121

Receptor for advanced glycation end products inhibits proliferation in osteoblast through suppression of Wnt, PI3K and ERK signaling.

Guofeng Li1, Jingren Xu, Zengchun Li.   

Abstract

Expression of receptor for advanced glycation end products (RAGE) plays a crucial role in bone metabolism. However, the role of RAGE in the control of osteoblast proliferation is not yet evaluated. In the present study, we demonstrate that RAGE overexpression inhibits osteoblast proliferation in vitro. The negative regulation of RAGE on cell proliferation results from suppression of Wnt, PI3K and ERK signaling, and is restored by RAGE neutralizing antibody. Prevention of Wnt signaling using Sfrp1 or DKK1 rescues RAGE-decreased PI3K and ERK signaling and cell proliferation, indicating that the altered cell growth in RAGE overexpressing cells is in part secondary to alterations in Wnt signaling. Consistently, RAGE overexpression inhibits the expression of Wnt targets cyclin D1 and c-myc, which is partially reversed by RAGE blockade. Overall, these results suggest that RAGE inhibits osteoblast proliferation via suppression of Wnt, PI3K and ERK signaling, which provides novel mechanisms by which RAGE regulates osteoblast growth.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22699121     DOI: 10.1016/j.bbrc.2012.06.015

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Impaired osteogenic differentiation and enhanced cellular receptor of advanced glycation end products sensitivity in patients with type 2 diabetes.

Authors:  Mattabhorn Phimphilai; Peraphan Pothacharoen; Prachya Kongtawelert; Nipon Chattipakorn
Journal:  J Bone Miner Metab       Date:  2016-11-21       Impact factor: 2.626

2.  Advanced glycosylation end product promotes forkhead box O1 and inhibits Wnt pathway to suppress capacities of epidermal stem cells.

Authors:  Jie Zhu; Peng Wang; Zhimin Yu; Wei Lai; Yi Cao; Pinbo Huang; Qiaodong Xu; Menglei Yu; Junyao Xu; Zitong Huang; Bing Zeng
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

3.  Advanced glycation endproducts regulate smooth muscle cells calcification in cultured HSMCs.

Authors:  Hu-Qiang He; Yong Liu; Hong Zeng; Xiao-Lei Sun; Lei Zhang; Xue-Lin Zhang; Wen-Jun Liao; Xiang-Yu Zhou; Yan-Zheng He
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 4.  Role of AGEs in the progression and regression of atherosclerotic plaques.

Authors:  Zhong-Qun Wang; Le-le Jing; Jin-Chuan Yan; Zhen Sun; Zheng-Yang Bao; Chen Shao; Qi-Wen Pang; Yue Geng; Li-Li Zhang; Li-Hua Li
Journal:  Glycoconj J       Date:  2018-07-10       Impact factor: 2.916

5.  The receptor for advanced glycation end products is required for β-catenin stabilization in a chemical-induced asthma model.

Authors:  Lihong Yao; Haijin Zhao; Haixiong Tang; Junjie Liang; Laiyu Liu; Hangming Dong; Fei Zou; Shaoxi Cai
Journal:  Br J Pharmacol       Date:  2016-07-27       Impact factor: 8.739

Review 6.  Diabetes, collagen, and bone quality.

Authors:  Mitsuru Saito; Yoshikuni Kida; Soki Kato; Keishi Marumo
Journal:  Curr Osteoporos Rep       Date:  2014-06       Impact factor: 5.096

7.  AGEs accumulation is related to muscle degeneration and vascular calcification in peritoneal dialysis patients.

Authors:  Laís de Faria Fonseca; Anna Beatriz Araújo; Kélcia Rosana da Silva Quadros; Cinthia Esbrile Moraes Carbonara; Sérgio San Juan Dertkigil; Andrei Carvalho Sposito; Rodrigo Bueno de Oliveira
Journal:  J Bras Nefrol       Date:  2021 Apr-Jun

Review 8.  Role of advanced glycation end products in cellular signaling.

Authors:  Christiane Ott; Kathleen Jacobs; Elisa Haucke; Anne Navarrete Santos; Tilman Grune; Andreas Simm
Journal:  Redox Biol       Date:  2014-01-09       Impact factor: 11.799

Review 9.  Role of miRNA let-7 and its major targets in prostate cancer.

Authors:  Siegfried Wagner; Anaclet Ngezahayo; Hugo Murua Escobar; Ingo Nolte
Journal:  Biomed Res Int       Date:  2014-09-03       Impact factor: 3.411

10.  Bone quality in diabetes.

Authors:  Mitsuru Saito; Keishi Marumo
Journal:  Front Endocrinol (Lausanne)       Date:  2013-06-14       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.